Hybrid Compound Design To Overcome the Gatekeeper T338M Mutation in cSrc
Author:
Affiliation:
1. Chemical Genomics Centre of the Max Planck Society, Otto-Hahn-Strasse 15, D-44227 Dortmund, Germany
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/jm9002928
Reference59 articles.
1. The discovery of receptor tyrosine kinases: targets for cancer therapy
2. Small-molecule inhibitors binding to protein kinases. Part I: exceptions from the traditional pharmacophore approach of type I inhibition
3. Small-molecule inhibitors binding to protein kinase. Part II: the novel pharmacophore approach of type II and type III inhibition
4. Targeting cancer with small molecule kinase inhibitors
5. Kinase Domain Mutations in Cancer: Implications for Small Molecule Drug Design Strategies
Cited by 125 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Design and synthesis of dual BRD4/Src inhibitors for treatment of triple-negative breast cancer;European Journal of Medicinal Chemistry;2024-01
2. Advances in protein kinase drug discovery through targeting gatekeeper mutations;Expert Opinion on Drug Discovery;2023-10-09
3. Advances in computational methods for ligand binding kinetics;Trends in Biochemical Sciences;2023-05
4. Anti-colorectal cancer of Ardisia gigantifolia Stapf. and targets prediction via network pharmacology and molecular docking study;BMC Complementary Medicine and Therapies;2023-01-09
5. Novel pyrazolo[3,4-d]pyrimidines as dual Src/Bcr-Abl kinase inhibitors: Synthesis and biological evaluation for chronic myeloid leukemia treatment;Bioorganic Chemistry;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3